Recipharm to acquire Kemwell

0
984

Swedish pharmaceutical contract development and manufacturing organization (CDMO) Recipharm has signed two separate agreements to acquire Kemwell’s pharmaceutical CDMO businesses.

Laboratory_testingKemwell has integrated facilities in India, Sweden and the US and a portfolio of services for sterile and non-sterile products from preformulation to commercial supply worldwide. It offers expertise in inhaled, nasal, oral, parenteral and topical dosage forms.

You must be a subscriber to read this content, or you can register for free to enjoy the current issue.

该部分内容仅提供予《商法》订阅会员。你可以订阅去解锁所有内容。你也可以免费注册去浏览最新一期的内容。